- European markets slightly down at the start of the week
- Ryanair results sour sentiment in airline sector
- Bayer drops sharply after new court ruling
Overall market situation:
European stock indices are trading in a mixed mood at the start of an interesting week. The German DAX is currently losing 0.51%, with DE40 contracts losing 0.3%. Investors' attention may turn towards the Dallas FED Manufacturing regional data in the US today. Tomorrow, Microsoft, Alphabet and AMD, among others, will present their results.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
European companies listed during Monday's trading session are currently trading at mixed levels. Source: xStation
The German benchmark DE40 is losing more than 0.3% during today's session. The benchmark is still trading in a broad consolidation zone close to historical highs. Source: xStation 5
News:
Companies in the aviation sector are trading today under downward pressure triggered by Ryanair's (RYAAY.US) weaker quarterly results. The main reason for the weaker results was largely due to higher fuel costs.
THIRD QUARTER RESULTS
- Adjusted profit after tax EUR 15 million, -93% y/y
- Operating loss EUR 18.9 million vs. profit EUR 151.4 million a year ago
- Revenues EUR 2.70 billion, +17% y/y, estimated EUR 2.72 billion
- Additional revenue €949.5m, +9.7% y/y, estimated €948m
- Planned revenue €1.75bn, +21% y/y, estimated €1.75bn
- Total operating expenses €2.72bn, +26% y/y, estimated €2.62bn
- Fuel and oil expenses €1.22bn, +34% y/y, estimated €1.17bn
- Airport and handling charges €326.4m, +14% y/y
- Depreciation and amortisation costs EUR 263.4 million, +24% y/y, estimated EUR 377.6 million
- Staff costs EUR 382.2 million, +30% y/y, estimated EUR 343.6 million
- Customers 41.4 million, +7.5% y/y, estimated 41.16 million
- Load factor 92% vs. 93% y/y, estimated 92.3%
Source: xStation
Bayer (BAYN.DE) shares are losing nearly 6% after the company was ordered to pay a $2.2 billion fine to a former Roundup user who blamed the herbicide for causing cancer. Analysts say the decision underscores the risks the company faces from legal action more broadly.
Source: xStation
Shares in Wacker Chemie (WCH.DE) are recovering from this morning's losses after the company stated in the release to its quarterly report that a recovery in demand "is not currently evident". Trading conditions appeared weak, but as analysts pointed out, this condition was anticipated.
PRELIMINARY RESULTS FOR 2023
Preliminary Ebitda €824m (14% lower than Morgan Stanley consensus)
Preliminary Ebitda margin 13%
Preliminary operating profit €405m
Preliminary net income €330m
Preliminary sales €6.4b
Analyst recommendations:
Barclays raised its recommendation on shares of ProSieben (PSM.DE) to an "overweight" rating.Target price of €8.
Hensoldt (HAG.DE) upgraded to a "buy" rating by Citi. Target price of €37.7.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
